Literature DB >> 7560066

Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints.

T Mima1, Y Saeki, S Ohshima, N Nishimoto, M Matsushita, M Shimizu, Y Kobayashi, T Nomura, T Kishimoto.   

Abstract

To investigate the pathogenicity of T cells infiltrating in the rheumatoid joints, mononuclear cells (MNC), predominantly T cells, isolated from either synovial fluid or synovial tissues of the patients with RA were transferred into severe combined immunodeficient (SCID) mice by intraarticular injections. According to our observations in this experimental system, patients with RA could be classified into at least two groups. In one group of patients, the infiltrating MNC induced synovial hyperplasia in the recipient SCID mice (the positive group). Whereas, in the other group no synovial hyperplasia was observed (the negative group). The induction of synovial hyperplasia observed in the positive group was prevented by an anti-human CD3 antibody (OKT3), indicating T cell mediation. Analysis of T cell receptor (TCR) V beta usage by reverse transcriptase polymerase chain reaction in the infiltrating MNC transferred into SCID mice revealed a marked skew towards the preferential use of certain V beta genes, which was not seen in the peripheral blood MNC, in only the positive group. The patterns of TCR/V beta skew were not uniform among the patients. The analysis of the PCR-amplified genes of such skewed TCR/ V beta by single strand conformational polymorphism showed distinct bands, indicating that the T cell populations expanding in rheumatoid joints of the positive group were oligoclonal. Furthermore, the enrichment of the T cell populations expressing such skewed TCR/V beta by in vitro stimulation of peripheral blood MNC of the patients with the relevant superantigen enabled the induction of synovial hyperplasia in the SCID mice. These results suggest that the pathogenic T cells could be activated locally in rheumatoid joints by certain antigens in some, but not in all patients with RA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560066      PMCID: PMC185811          DOI: 10.1172/JCI118220

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Predominantly T-cell infiltrate in rheumatoid synovial membranes.

Authors:  J A Van Boxel; S A Paget
Journal:  N Engl J Med       Date:  1975-09-11       Impact factor: 91.245

2.  The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal.

Authors:  Y Uematsu; H Wege; A Straus; M Ott; W Bannwarth; J Lanchbury; G Panayi; M Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis.

Authors:  G R Burmester; D T Yu; A M Irani; H G Kunkel; R J Winchester
Journal:  Arthritis Rheum       Date:  1981-11

4.  Lymphapheresis in rheumatoid arthritis. A randomized trial.

Authors:  J Karsh; J H Klippel; P H Plotz; J L Decker; D G Wright; M W Flye
Journal:  Arthritis Rheum       Date:  1981-07

5.  Elution and characterization of lymphocytes from rheumatoid inflammatory tissue.

Authors:  T G Abrahamsen; S S Froland; J B Natvig; J Pahle
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

6.  Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation.

Authors:  G Janossy; G Panayi; O Duke; M Bofill; L W Poulter; G Goldstein
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

7.  Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

Authors:  Y Iwakura; M Tosu; E Yoshida; M Takiguchi; K Sato; I Kitajima; K Nishioka; K Yamamoto; T Takeda; M Hatanaka
Journal:  Science       Date:  1991-08-30       Impact factor: 47.728

8.  T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones.

Authors:  R Holmdahl; L Klareskog; K Rubin; E Larsson; H Wigzell
Journal:  Scand J Immunol       Date:  1985-09       Impact factor: 3.487

9.  An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies.

Authors:  O Duke; G S Panayi; G Janossy; L W Poulter
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

10.  Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.

Authors:  G E Ranges; S Sriram; S M Cooper
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis?

Authors:  Louise C Pollard
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Adhesion molecules in rheumatoid arthritis.

Authors:  N Oppenheimer-Marks; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies.

Authors:  J D Cañete; S E Martínez; J Farrés; R Sanmartí; M Blay; A Gómez; G Salvador; J Muñoz-Gómez
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

4.  Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy.

Authors:  S Ohshima; Y Saeki; T Mima; M Sasai; K Nishioka; H Ishida; M Shimizu; M Suemura; R McCloskey; T Kishimoto
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

5.  Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4.

Authors:  P Isomäki; R Luukkainen; O Lassila; P Toivanen; J Punnonen
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

6.  [Selective co-stimulation blockade. CTLA4-Ig (Abatacept)].

Authors:  R Alten; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

7.  TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.

Authors:  Reiko Horai; Akiko Nakajima; Katsuyoshi Habiro; Motoko Kotani; Susumu Nakae; Taizo Matsuki; Aya Nambu; Shinobu Saijo; Hayato Kotaki; Katsuko Sudo; Akihiko Okahara; Hidetoshi Tanioka; Toshimi Ikuse; Naoto Ishii; Pamela L Schwartzberg; Ryo Abe; Yoichiro Iwakura
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

8.  Association and expression study of PRKCH gene in a French Caucasian population with rheumatoid arthritis.

Authors:  Vitor Hugo Teixeira; Laurent Jacq; Jeoiakim Moore; Sandra Lasbleiz; Pascal Hilliquin; Catarina Resende Oliveira; François Cornelis; Elisabeth Petit-Teixeira
Journal:  J Clin Immunol       Date:  2007-10-24       Impact factor: 8.317

9.  Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial).

Authors:  P Emery; P Durez; M Dougados; C W Legerton; J-C Becker; G Vratsanos; H K Genant; C Peterfy; P Mitra; S Overfield; K Qi; R Westhovens
Journal:  Ann Rheum Dis       Date:  2009-11-23       Impact factor: 19.103

Review 10.  The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction.

Authors:  Danielle Burger; Jean-Michel Dayer
Journal:  Arthritis Res       Date:  2002-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.